Alan D T Barrett researcher
Barrett, Alan D.T.
Barrett, A. D. T.
Barrett, A. D. T. (Alan D. T.)
VIAF ID: 51196658 (Personal)
Permalink: http://viaf.org/viaf/51196658
Preferred Forms
- 100 0 _ ‡a Alan D T Barrett ‡c researcher
- 200 _ | ‡a Barrett ‡b A. D. T.
-
- 100 1 _ ‡a Barrett, A. D. T. ‡q (Alan D. T.)
-
- 100 1 _ ‡a Barrett, Alan D. T
- 100 1 _ ‡a Barrett, Alan D. T. (sparse)
-
- 100 1 _ ‡a Barrett, Alan D.T.
- 100 1 _ ‡a Barrett, Alan D.T.
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Defective interfering viruses and infections of animals | |
Fire and home range expansion: a behavioral response to burning among savanna dwelling vervet monkeys (Chlorocebus aethiops). | |
Flavivirus DNA vaccine with a kick | |
Flavivirus-induced antibody cross-reactivity | |
Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues | |
Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice. | |
Genetic divergence and dispersal of yellow fever virus, Brazil | |
Genetic diversity of Japanese encephalitis virus isolates obtained from the Indonesian archipelago between 1974 and 1987 | |
Genetic variation of St. Louis encephalitis virus | |
Genomic Characterization of Crimean-Congo Hemorrhagic Fever Virus in Hyalomma Tick from Spain, 2014. | |
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses | |
Home range utilization by chacma baboon (Papio ursinus) troops on Suikerbosrand Nature Reserve, South Africa. | |
How Well-Informed Are Pension Scheme Members on Their Future Pension Benefits? Evidence from Ireland | |
immune response to influenza infection | |
Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain | |
The Impact of Voluntary and Involuntary Retirement on Mental Health: Evidence from Older Irish Adults | |
Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones | |
International laboratory network for yellow fever vaccine-associated adverse events | |
Invasion Dynamics of Teratogenic Infections in Light of Rubella Control: Implications for Zika Virus | |
Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice | |
Japanese encephalitis and West Nile viruses, c2002: | |
A lethal model of disseminated dengue virus type 1 infection in AG129 mice | |
Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States | |
Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day | |
Molecular determinants of antigenicity of two subtypes of the tick-borne flavivirus Omsk haemorrhagic fever virus | |
Molecular evolution of lineage 2 West Nile virus | |
Mouse models of dengue virus infection for vaccine testing | |
Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype | |
Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness | |
Multiple pathways to the attenuation of West Nile virus in south-east Texas in 2003. | |
Mutational analysis of the West Nile virus NS4B protein | |
Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape | |
Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders | |
Next generation dengue vaccines: a review of candidates in preclinical development | |
The old and the new: successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century | |
Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas | |
Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus | |
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype | |
Phylogeographic reconstruction of African yellow fever virus isolates indicates recent simultaneous dispersal into east and west Africa | |
Phylogeography of Japanese encephalitis virus: genotype is associated with climate | |
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas | |
Recombination and flavivirus vaccines: a commentary | |
regulation of lymphocyte traffic | |
Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done? | |
Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development | |
Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. | |
Selection of thioaptamers for diagnostics and therapeutics. | |
Short report: comparison of oral infectious dose of West Nile virus isolates representing three distinct genotypes in Culex quinquefasciatus | |
Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus | |
Structure of yellow fever virus envelope protein domain III | |
Susceptibility of a North American Culex quinquefasciatus to Japanese Encephalitis Virus | |
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy. | |
Terrestrial Bird Migration and West Nile Virus Circulation, United States | |
Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses | |
Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections | |
Tibialis anterior EMG activation pattern changes with walking speed during over ground and treadmill walking. | |
Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection | |
Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses | |
Vaccines and vaccination against tick-borne encephalitis | |
Vaccines for biodefense and emerging and neglected diseases | |
Vaccinology : an essential guide | |
Vaccinology in the twenty-first century | |
Vertebrate attenuated West Nile virus mutants have differing effects on vector competence in Culex tarsalis mosquitoes | |
West Nile virus in Mexico: evidence of widespread circulation since July 2002. | |
West Nile Virus isolation in human and mosquitoes, Mexico | |
West Nile virus: where are we now? | |
WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009 | |
Within- and Between-Session Prefrontal Cortex Response to Virtual Reality Exposure Therapy for Acrophobia | |
Yellow fever: a disease that has yet to be conquered | |
Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand | |
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? | |
Yellow fever virus infectivity for Bolivian Aedes aegypti mosquitoes | |
Zika vaccine candidates progress through nonclinical development and enter clinical trials |